New Out Licensing Program for Liquid Biopsy Technology

San Diego, CA (PRWEB) May 28, 2015 Today, Proxy Life Science Holdings (Proxy) launched a patent licensing program to enable widely available access of its seminal exosome RNA technology to academia and industry for molecular diagnostic and research tool applications. The company’s Proxysome™ technology allows for detection of genetic markers circulating within blood and other ...